In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Q: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Freedom and Mobility in Consumer 
Banking Act''.

SEC. 2. FEDERAL DEPOSIT INSURANCE ACT AMENDMENTS.

    The Federal Deposit Insurance Act (12 U.S.C. 1811 et seq.) is 
amended by adding at the end the following new section:

``SEC. 51. RIGHT TO CLOSE PERSONAL CHECKING AND SAVINGS ACCOUNTS.

    ``(a) In General.--An insured depository institution may not--
            ``(1) prohibit any person from closing a checking or 
        savings account, regardless of whether the balance in the 
        account is positive, zero, or negative; or
            ``(2) charge any fee to close any such account.
    ``(b) Time Limit.--An account at any insured depository institution 
shall be closed by the institution not later than 48 hours after 
receiving a request from the customer to close the account.
    ``(c) Methods of Requesting Closure of an Account.--
            ``(1) In general.--Any accountholder of an account at an 
        insured depository institution may request that the account be 
        closed in person, over the phone, or by other electronic or 
        remote means, as may be prescribed by regulation.
            ``(2) Exception for large accounts.--Notwithstanding 
        paragraph (1), any insured depository institution may require 
        an accountholder of an account which has an outstanding balance 
        of $25,000 or more on deposit at the depository institution to 
        close the account in person, to the extent the depository 
        institution has provided written notice of such requirement to 
        the account holder at any time prior to receiving a request 
        from the accountholder to close the account.
    ``(d) Repayment of Balances.--
            ``(1) In general.--Any balance in an account at an insured 
        depository institution that is closed by the institution 
        pursuant to a request by the accountholder shall repaid to the 
        accountholder in accordance with the following requirements:
                    ``(A) In person.--If the request is made in person, 
                the total amount of funds on deposit in the account 
                shall be paid to the accountholder at the time the 
                request is made at the consumer's option and without a 
                fee, by certified check provided to the consumer at the 
                time of the request, by electronic fund transfer 
                executed on that business day to an account designated 
                by the consumer, or by any other means offered by the 
                financial institution if requested by the consumer.
                    ``(B) Request made by other means.--If the request 
                is made over the phone, or by other electronic or 
                remote means, the total amount of funds on deposit in 
                the account shall promptly be remitted by the 
                institution to the accountholder at the consumer's 
                option and without a fee, by certified check issued on 
                the business day on which the request is received, by 
                electronic fund transfer executed on that business day 
                to an account designated by the consumer, or by any 
                other means offered by the financial institution if 
                requested by the consumer.
            ``(2) Time limit.--In any case, the payment by an insured 
        depository institution of the total amount of funds on deposit 
        in an account at the institution which the accountholder has 
        requested be closed shall be remitted to the accountholder 
        before the end of the 3 business day period beginning when the 
        accountholder submits such request.
    ``(e) Prohibition on Any Fees or Charges After Request To Close.--
No insured depository institution may impose any fees or charges on any 
deposit account at such institution after receiving a request in 
accordance with subsection (c) to close the account.
    ``(f) Prohibition on Reopening Account To Make Subsequent 
Payment.--No insured depository institution may reopen an account that 
the consumer has requested be closed in accordance with subsection (c) 
to apply subsequent debits, whether preauthorized or otherwise, or for 
any other reason, unless the consumer expressly requests that such 
account be reopened.
    ``(g) Notice of Subsequent Preauthorized Recurring Debits.--During 
the 30-day period beginning on the date an account at an insured 
depository institution is closed pursuant to a request by the 
accountholder, the insured depository institution shall promptly notify 
the customer if a preauthorized recurring debit is directed to the 
account.
    ``(h) Limitation on Reporting.--
            ``(1) Negative balance resulting from fees.--If, at the 
        time any account at an insured depository institution is 
        closed, the account has a negative balance resulting solely 
        from any fee assessed by the depository institution, the 
        insured depository institution may not report the fact of the 
        outstanding balance or any other adverse information with 
        respect to such account to any consumer reporting agency 
        described in section 603(f) of the Fair Credit Reporting Act if 
        such information could be used to adversely affect the 
        consumer's ability to open a transaction account at another 
        depository institution.
            ``(2) Treatment of negative balance resulting from 
        overdrafts.--If such information could be used to adversely 
        affect the consumer's ability to open a transaction account at 
        another depository institution, an insured depository 
        institution shall not report to any consumer reporting agency 
        (as defined in section 603 of the Fair Credit Reporting Act) 
        that an account had a negative balance at the time of the 
        closure of the account unless all of the following conditions 
        are met:
                    ``(A) Only if the negative balance is the result of 
                funds actually paid by the depository institution to a 
                third party.
                    ``(B) Only for the amount it actually paid to the 
                third party and not for any fees associated with the 
                transaction.
                    ``(C) Only to the extent the negative balance is 
                the result of credit extended through an overdraft line 
                of credit program where the fee or charge incurred in 
                connection with the overdraft is considered a finance 
                charge under the Truth In Lending Act.
            ``(3) Notice and opportunity for repayment of overdraft.--
        If an account of an accountholder at an insured depository 
        institution has a negative balance at the time the account is 
        closed, the insured depository institution--
                    ``(A) shall promptly notify the accountholder of 
                the fact of the negative balance and the amount due; 
                and
                    ``(B) may, after the end of the 30-day period 
                beginning on the date notice is provided to an 
                accountholder under subparagraph (A)--
                            ``(i) report the fact of the outstanding 
                        balance or any other adverse information with 
                        respect to such account to any consumer 
                        reporting agency, subject to the limitations in 
                        paragraph (2); and
                            ``(ii) take any other collection activity 
                        with respect to such outstanding balance.
    ``(i) Transfer of Direct Deposit Received After Notice of Closure 
and Payment.--If--
            ``(1) during the 30-day period beginning after any balance 
        in an account at an insured depository institution that is 
        closed by the institution pursuant to a request by the 
        accountholder has been repaid to the accountholder, a 
        previously scheduled amount intended for direct deposit into 
        such account is received by such institution, and
            ``(2) before the time such amount is received, the consumer 
        provides the insured depository institution with an account 
        number and insured depository institution routing number for a 
        successor transaction or savings account at another insured 
        depository institution,
the insured depository institution which receives such amount shall 
transfer such amount, without a fee and by electronic fund transfer, to 
the insured depository institution identified by the former 
accountholder for deposit in the transaction or savings account 
identified by such former accountholder.
    ``(j) Regulations.--The Federal banking agencies shall jointly 
prescribe regulations to carry out the purposes of this section.''.

A: Freedom and Mobility in Consumer Banking Act - Amends the Federal Deposit Insurance Act (FDIA) to prohibit an insured depository institution from: (1) prohibiting any person from closing a checking or savings account, regardless of its balance; or (2) charging a fee to close such an account.

Requires a depository institution to close an account within 48 hours after receiving a request from the customer to do so.

Permits an account holder to request that the account be closed in person, over the phone, or by other electronic or remote means, as may be prescribed by regulation.

Sets forth financial institution procedures for closing large accounts and repaying balances, as well as notice and opportunity for accountholder repayment of overdrafts.

Prohibits a depository institution from: (1) imposing fees or charges after receiving a request to close an account, or (2) reopening an account without express account holder request.
****
Q: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Genetically Engineered Food Right-
to-Know Act''.

SEC. 2. PURPOSE AND FINDINGS.

    (a) Purpose.--The purpose of this Act is to establish a consistent 
and enforceable standard for labeling of foods produced using genetic 
engineering, including fish, thereby providing consumers with knowledge 
of how their food is produced.
    (b) Findings.--Congress finds that--
            (1) the process of genetically engineering food organisms 
        results in material changes to food derived from those 
        organisms;
            (2) the Food and Drug Administration requires the labeling 
        of more than 3,000 ingredients, additives, and processes;
            (3) individuals in the United States have a right to know 
        if their food was produced with genetic engineering for a 
        variety of reasons, including health, economic, environmental, 
        religious, and ethical;
            (4) more than 60 countries, including the United Kingdom 
        and all other countries of the European Union, South Korea, 
        Japan, Brazil, Australia, India, China, and other key United 
        States trading partners have laws or regulations mandating 
        disclosure of genetically engineered food on food labels;
            (5) in 2011, Codex Alimentarius, the food standards 
        organization of the United Nations, adopted a text that 
        indicates that governments can decide on whether and how to 
        label foods produced with genetic engineering; and
            (6) mandatory identification of food produced with genetic 
        engineering can be a critical method of preserving the economic 
        value of exports or domestically sensitive markets with 
        labeling requirements for genetically engineered foods.

SEC. 3. AMENDMENTS TO THE FEDERAL FOOD, DRUG, AND COSMETIC ACT.

    (a) In General.--Section 403 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 343) is amended by adding at the end the 
following:
    ``(z)(1) If it is a food that has been genetically engineered or 
contains 1 or more genetically engineered ingredients, unless such 
information is clearly disclosed, as determined by the Secretary.
    ``(2) This paragraph does not apply to food that--
            ``(A) is served in restaurants or other similar eating 
        establishments, such as cafeterias and carryouts;
            ``(B) is a medical food (as defined in section 5(b) of the 
        Orphan Drug Act);
            ``(C) is a food that would be subject to this paragraph 
        solely because it was produced using a genetically engineered 
        vaccine; or
            ``(D) is a food or processed food that would be subject to 
        this paragraph solely because it includes the use of a 
        genetically engineered processing aid (including yeast) or 
        enzyme.
    ``(3) In this paragraph:
            ``(A) The term `genetic engineering' means a process 
        involving the application of--
                    ``(i) in vitro nucleic acid techniques, including 
                recombinant deoxyribonucleic acid (DNA) and direct 
                injection of nucleic acid into cells or organelles; or
                    ``(ii) fusion of cells beyond the taxonomic family 
                that--
                            ``(I) overcome natural physiological 
                        reproductive or recombinant barriers; and
                            ``(II) are not techniques used in 
                        traditional breeding and selection.
            ``(B) The term `genetically engineered', used with respect 
        to a food, means a material intended for human consumption that 
        is--
                    ``(i) an organism that is produced through the 
                intentional use of genetic engineering; or
                    ``(ii) the progeny of intended sexual or asexual 
                reproduction (or both) of 1 or more organisms that is 
                the product of genetic engineering.
            ``(C) The term `genetically engineered ingredient' means a 
        material that is an ingredient in a food that is derived from 
        any part of an organism that has been genetically engineered, 
        without regard to whether--
                    ``(i) the altered molecular or cellular 
                characteristics of the organism are detectable in the 
                material; and
                    ``(ii) the organism is capable for use as human 
                food.''.
    (b) Guaranty.--
            (1) In general.--Section 303(d) of the Federal Food, Drug, 
        and Cosmetic Act (21 U.S.C. 333(d)) is amended--
                    (A) by striking ``(d)'' and inserting ``(d)(1)''; 
                and
                    (B) by adding at the end the following:
            ``(2)(A) No person shall be subject to the penalties of 
        subsection (a)(1) for a violation of subsection (a), (b), or 
        (c) of section 301 involving food that is misbranded within the 
        meaning of section 403(z) if such person (referred to in this 
        paragraph as the `recipient') establishes a guaranty or 
        undertaking that--
                    ``(i) is signed by, and contains the name and 
                address of, a person residing in the United States from 
                whom the recipient received in good faith the food 
                (including the receipt of seeds to grow raw 
                agricultural commodities); and
                    ``(ii) contains a statement to the effect that the 
                food is not genetically engineered or does not contain 
                a genetically engineered ingredient.
            ``(B) In the case of a recipient who, with respect to a 
        food, establishes a guaranty or undertaking in accordance with 
        subparagraph (A), the exclusion under such subparagraph from 
        being subject to penalties applies to the recipient without 
        regard to the manner in which the recipient uses the food, 
        including whether the recipient is--
                    ``(i) processing the food;
                    ``(ii) using the food as an ingredient in a food 
                product;
                    ``(iii) repacking the food; or
                    ``(iv) growing, raising, or otherwise producing the 
                food.
            ``(C) No person may avoid responsibility or liability for a 
        violation of subsection (a), (b), or (c) of section 301 
        involving food that is misbranded within the meaning of section 
        403(z) by entering into a contract or other agreement that 
        specifies that another person shall bear such responsibility or 
        liability, except that a recipient may require a guaranty or 
        undertaking as described in this subsection.
            ``(D) In this subsection, the terms `genetically 
        engineered' and `genetically engineered ingredient' have the 
        meanings given the terms in section 403(z).''.
            (2) False guaranty.--Section 301(h) of the Federal Food, 
        Drug, and Cosmetic Act (21 U.S.C. 331(h)) is amended by 
        inserting ``or 303(d)(2)'' after ``section 303(c)(2)''.
    (c) Unintended Contamination.--Section 303(d) of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 333(d)), as amended by subsection 
(b), is further amended by adding at the end the following:
            ``(3)(A) No person shall be subject to the penalties of 
        subsection (a)(1) for a violation of subsection (a), (b), or 
        (c) of section 301 involving food that is misbranded within the 
        meaning of section 403(z) if--
                    ``(i) such person is an agricultural producer and 
                the violation occurs because food that is grown, 
                raised, or otherwise produced by such producer, which 
                food does not contain a genetically engineered material 
                and was not produced with a genetically engineered 
                material, is contaminated with a food that contains a 
                genetically engineered material or was produced with a 
                genetically engineered material; and
                    ``(ii) such contamination is not intended by the 
                agricultural producer.
            ``(B) Subparagraph (A) does not apply to an agricultural 
        producer to the extent that the contamination occurs as a 
        result of the negligence of the producer.''.
    (d) Promulgation of Regulations.--Not later than 1 year after the 
date of enactment of this Act, the Secretary shall promulgate proposed 
regulations establishing labeling requirements for compliance in 
accordance with section 403(z) of the Federal Food, Drug, and Cosmetic 
Act, as added by subsection (a).

A: Genetically Engineered Food Right-to-Know Act - Amends the Federal Food, Drug, and Cosmetic Act to deem misbranded any food that has been genetically engineered or contains one or more genetically engineered ingredients, unless such information is clearly disclosed. Exempts from this requirement any food that: (1) is served in restaurants or other similar eating establishments, (2) is a medical food, (3) would be subject to such requirement solely because it was produced using a genetically engineered vaccine, or (4) would be subject to such requirement solely because it includes the use of a genetically engineered processing aid (including yeast) or enzyme. Defines &quot;genetically engineered&quot; as a material intended for human consumption that is: (1) an organism produced through the intentional use of genetic engineering, or (2) the progeny of intended sexual or asexual reproduction (or both) of one or more organisms that is the product of genetic engineering. Defines &quot;genetically engineered ingredient&quot; as an ingredient in a food that is derived from any part of an organism that has been genetically engineered, without regard to whether: (1) the altered molecular or cellular characteristics of the organism are detectable in the material, and (2) the organism is capable for use as human food. Excludes from penalties for misbranding of genetically engineered food or ingredients any recipient that establishes a guaranty or undertaking that: (1) is signed by, and contains the name and address of, a person residing in the United States from whom the recipient received the food in good faith (including the receipt of seeds to grow raw agricultural commodities); and (2) contains a statement to the effect that the food is not genetically engineered or does not contain a genetically engineered ingredient. Applies this exclusion from penalties without regard to the manner in which the recipient uses the food. Excludes an agricultural producer also from such penalties when a violation occurs because food the producer has grown, raised, or otherwise produced, which neither contains nor was produced with a genetically engineered material, is subsequently contaminated with a food that does contain or was produced with a genetically engineered material, and the agricultural producer has not intended any such contamination nor was negligent in the matter.
****
Q: SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``Uniformed Services 
Medicare Subvention Demonstration Project Act''.
    (b) Table of Contents.--The table of contents of this Act is as 
follows:

Sec. 1. Short title; table of contents.
Sec. 2. Definitions.
Sec. 3. Establishment of demonstration project.
Sec. 4. Determination of reimbursement amounts.
Sec. 5. Reporting requirements.

SEC. 2. DEFINITIONS.

    For purposes of this Act:
            (1) Medicare-eligible covered military beneficiary.--The 
        term ``medicare-eligible covered military beneficiary'' means a 
        beneficiary under chapter 55 of title 10, United States Code, 
        who--
                    (A) is entitled to hospital insurance benefits 
                under part A of title XVIII of the Social Security Act 
                (42 U.S.C. 1395c et seq.);
                    (B) is enrolled in the supplementary medical 
                insurance program under part B of such title (42 U.S.C. 
                1395j et seq.); and
                    (C) resides within a geographic area designated 
                under section 3(b) as a location for the demonstration 
                project.
            (2) TRICARE program.--The term ``TRICARE program'' means 
        the managed health care program that is established by the 
        Secretary of Defense under the authority of chapter 55 of title 
        10, United States Code, principally section 1097 of such title, 
        and includes the competitive selection of contractors to 
        financially underwrite the delivery of health care services 
        under the Civilian Health and Medical Program of the Uniformed 
        Services.
            (3) Demonstration project.--The term ``demonstration 
        project'' means the uniformed services medicare subvention 
        demonstration project established under section 3.
            (4) Secretaries.--The term ``Secretaries'' means the 
        Secretary of Defense and the Secretary of Health and Human 
        Services acting jointly, except that in section 6, the term 
        means the Secretary of Veterans Affairs and the Secretary of 
        Health and Human Services acting jointly.

SEC. 3. ESTABLISHMENT OF DEMONSTRATION PROJECT.

    (a) Establishment Required.--The Secretary of Defense and the 
Secretary of Health and Human Services shall jointly establish a 
demonstration project to provide the Department of Defense with 
reimbursement, in accordance with section 4, from the medicare program 
under title XVIII of the Social Security Act (42 U.S.C. 1395 et seq.) 
for health care services provided to medicare-eligible covered military 
beneficiaries who enroll in the demonstration project and receive the 
health care services through the managed care option of the TRICARE 
program.
    (b) Location of Project.--The Secretaries shall conduct the 
demonstration project in not more than five geographic areas of the 
United States designated by the Secretaries.
    (c) Duration.--The Secretaries shall conduct the demonstration 
project during the three-year period beginning on January 1, 1998.
    (d) Voluntary Enrollment; Effect of Enrollment.--Enrollment of 
medicare-eligible covered military beneficiaries in the demonstration 
project shall be voluntary, subject to the capacity and funding 
limitations specified in section 4. In the case of a medicare-eligible 
covered military beneficiary who enrolls in the demonstration project, 
payments may not be made under title XVIII of the Social Security Act 
(42 U.S.C. 1395 et seq.) other than for health care services provided 
through the demonstration project, except that the Secretaries may 
provide exceptions for emergencies or other situations as the 
Secretaries consider appropriate.
    (e) TRICARE Program Enrollment Fee Waiver.--The Secretary of 
Defense shall waive the enrollment fee applicable to any medicare-
eligible covered military beneficiary enrolled in the managed care 
option of the TRICARE program for whom reimbursement may be made under 
section 4.
    (f) Modification of TRICARE Contracts.--In carrying out the 
demonstration project, the Secretary of Defense may amend existing 
TRICARE program contracts to incorporate provisions applicable to 
medicare-eligible covered military beneficiaries enrolled in the 
demonstration project.
    (g) Cost Sharing.--The Secretary of Defense may establish cost 
sharing requirements for medicare-eligible covered military 
beneficiaries who enroll in the demonstration project.
    (h) Expansion of Demonstration Project.--The Secretaries shall 
include in the demonstration project a provision for expanding the 
demonstration project to incorporate health care services provided to 
medicare-eligible covered military beneficiaries under the fee-for-
service options of the TRICARE program if, in the report submitted 
under section 713 of the National Defense Authorization Act for Fiscal 
Year 1997 (Public Law 104-106; 110 Stat. 2591), the Secretaries 
determined that such expansion of the demonstration project is feasible 
and advisable.

SEC. 4. DETERMINATION OF REIMBURSEMENT AMOUNTS.

    (a) Reimbursement of Department of Defense.--
            (1) Basis of payments.--Monthly payments to the Department 
        of Defense under the demonstration project from the medicare 
        program under title XVIII of the Social Security Act (42 U.S.C. 
        1395 et seq.) shall be made on the basis that payments are made 
        under section 1876(a) of such Act (42 U.S.C. 1395mm(a)).
            (2) Amount of payments.--Subject to subsection (c), the 
        Secretary of Health and Human Services shall make payments to 
        the Department of Defense from the Federal Hospital Insurance 
        Trust Fund and the Federal Supplementary Medical Insurance 
        Trust Fund (allocated by the Secretary of Health and Human 
        Services between each trust fund based on the relative weight 
        that each trust fund contributes to the required payment) at a 
        per capita rate equal to 93 percent of the applicable adjusted 
        average per capita cost for each medicare-eligible covered 
        military beneficiary enrolled in the demonstration project in 
        excess of the number of such beneficiaries calculated under 
        subsection (b)(4) for the Department of Defense maintenance of 
        health care effort.
    (b) Maintenance of Defense Health Care Effort.--
            (1) Maintenance of effort required.--The Secretary of 
        Defense shall maintain the Department of Defense health care 
        efforts for medicare-eligible covered military beneficiaries so 
        as to avoid the imposition on the medicare program of the costs 
        of health care that medicare-eligible covered military 
        beneficiaries would be expected to receive from the Department 
        of Defense in the absence of the demonstration project.
            (2) Estimate of prior effort.--The Secretaries shall 
        estimate the amount expended by the Department of Defense for 
        fiscal year 1997 for providing health care items and services 
        (other than pharmaceuticals provided to outpatients) to 
        medicare-eligible covered military beneficiaries. Such amount 
        shall be adjusted for inflation after the first year of the 
        demonstration project, for differences between estimated and 
        actual amounts expended, and for changes in the Department of 
        Defense health care budget that exceed $100,000,000.
            (3) Distribution of effort.--The amount determined and 
        adjusted under paragraph (2) shall be divided into a portion 
        devoted to providing health care services to medicare-eligible 
        covered military beneficiaries who do not enroll in the 
        demonstration project (which of the total amount may not exceed 
        70 percent in the first year, 60 percent in the second year, 
        and 50 percent in the third year) and a portion devoted to 
        medicare-eligible covered military beneficiaries who are 
        enrolled in the demonstration project.
            (4) Target for defense effort.--The Secretaries shall 
        establish monthly targets for the number of medicare-eligible 
        covered military beneficiaries enrolled in the demonstration 
        project necessary to meet the maintenance of effort portion 
        devoted to such beneficiaries under paragraph (3).
    (c) Annual Limit on Use of Medicare Funds.--Annual medicare 
payments to the Department of Defense under subsection (a) for the 
demonstration project may not exceed $65,000,000.
    (d) Protection of Medicare Program Against Increased Costs.--
            (1) Purpose.--The purpose of this subsection is to protect 
        the medicare program against costs incurred in connection with 
        the provision of health care services to medicare-eligible 
        covered military beneficiaries enrolled in the demonstration 
        project that would not have been incurred by the medicare 
        program in the absence of the reimbursement requirement under 
        subsection (a).
            (2) Additional protections.--If the Secretaries determine 
        that the trust funds under title XVIII of the Social Security 
        Act (42 U.S.C. 1395 et seq.) still incur excess costs as a 
        result of the demonstration project, the Secretaries shall take 
        such steps as may be necessary to offset those excess costs 
        (and prevent future excess costs), including suspension or 
        termination of the demonstration project or adjustment of the 
        payment rate under subsection (a)(2).
    (e) Review by Comptroller General.--Not later than December 31 of 
each year in which the demonstration project is conducted, the 
Comptroller General shall determine and submit to the Secretaries and 
Congress a report on the extent, if any, to which the costs of the 
Secretary of Defense under the TRICARE program and the costs of the 
Secretary of Health and Human Services under the medicare program have 
increased as a result of the project.
    (f) Demonstration Project Adjustments Following Review.--Based on 
the review prepared under subsection (e), the Secretaries shall modify 
the demonstration project at the end of each year as provided in 
subsection (d)(2) to correct for any discrepancy between cost targets 
and actual spending under the demonstration project. The Secretaries 
shall provide for an annual reconciliation of payments to ensure that 
actual costs incurred by the Secretary of Defense to provide health 
care services to medicare-eligible covered military beneficiaries, 
exclusive of payments from the Secretary of Health and Human Services 
under subsection (a), met the maintenance of effort requirements under 
subsection (b).

SEC. 5. REPORTING REQUIREMENTS.

    Not later than 15 months after the establishment of the 
demonstration project, and then not later than 90 days after the end of 
the demonstration project, the Secretaries shall submit to Congress a 
report containing the following:
            (1) The number of medicare-eligible covered military 
        beneficiaries enrolling in the demonstration project instead of 
        receiving health benefits through another health insurance plan 
        (including through the medicare program).
            (2) An analysis of whether, and in what manner, easier 
        access to the military treatment system affects the number of 
        medicare-eligible covered military beneficiaries receiving 
        health benefits under the medicare program.
            (3) A list of the health insurance plans and programs that 
        were the primary payers for medicare-eligible covered military 
        beneficiaries during the year prior to their enrollment in the 
        demonstration project and the distribution of their previous 
        enrollment in such plans and programs.
            (4) An identification of cost-shifting (if any) among 
        medical care programs as a result of the demonstration project 
        and a description of the nature of any such cost-shifting.
            (5) An analysis of how the demonstration project affects 
        the overall accessibility of the military treatment system and 
        the amount of space available for point-of-service care and a 
        description of the unintended effects (if any) upon the normal 
        treatment priority system.
            (6) A description of the difficulties (if any) experienced 
        by the Department of Defense in managing the demonstration 
        project.
            (7) A description of the effects of the demonstration 
        project on military treatment facility readiness and training 
        and the probable effects of the project on overall Department 
        of Defense medical readiness and training.
            (8) A description of the effects that the demonstration 
        project, if permanent, would be expected to have on the overall 
        budget of the military health care system and the budgets of 
        individual military treatment facilities.
            (9) An analysis of whether the demonstration project 
        affects the cost to the Department of Defense of prescription 
        drugs or the accessibility, availability, and cost of such 
        drugs to program beneficiaries.

A:
Uniformed Services Medicare Subvention Demonstration Project Act - Directs the Secretaries of Defense and Health and Human Services (HHS) to jointly establish a demonstration project to provide the Department of Defense (DOD) with reimbursement, under provisions of title XVIII (Medicare) of the Social Security Act, for health services provided to Medicare-eligible covered military beneficiaries who participate in the project and receive such services through the managed care option of the TRICARE program (a DOD managed health care program).  Requires the project to be conducted during the three-year period beginning on January 1, 1998, in no more than five geographic regions designated by the Secretaries.  Makes project enrollment voluntary.  Requires the Secretary of Defense to waive the TRICARE enrollment fee for project participants for whom Medicare reimbursement may be made.  Requires inclusion in the project of a provision for expansion to incorporate health care services provided to such beneficiaries under the fee-for-services options of the TRICARE program if the Secretaries determine that such expansion is feasible and advisable. 
Directs the HHS Secretary to make monthly payments to DOD from the Federal Hospital Insurance Trust Fund and the Federal Supplementary Medical Insurance Trust Fund representing appropriate reimbursement amounts.  Provides for the determination of such amounts. 
Directs the Secretary of Defense to:  (1) maintain the DOD health care efforts for Medicare-eligible covered military beneficiaries; (2) estimate the amount expended by DOD for FY 1997 for providing health care items and services to such beneficiaries; and (3) establish monthly targets for the number of such beneficiaries enrolled in the project necessary to meet DOD maintenance of health care efforts for such individuals.  Limits to $65 million the annual payments to DOD for the project. 
Requires the Comptroller General, for each project year, to submit to the Secretaries and the Congress a report on the extent to which costs under the TRICARE program and the Medicare program have increased as a result of the project.  Directs the Secretaries to modify the project at the end of each year to correct for any discrepancy between cost targets and actual spending under the project. 
Directs the Secretaries to submit to the Congress an interim and final report on various project aspects.
****